Congratulations to Mi-Sun Jang for receiving the 2021 Joachim Herz Fellowhip. New insights into macrophage ontogeny will accelerate macrophage-based therapies.
Macrophage-Therapies against Staphylococcus aureus lung infections. Publication published in Blood Advance journal. Fore more information click here.
Read more about our lab´s latest approaches in CARs and macrophages targeting macrophage-based therapies in cancer and beyond. For more information click here.
Congratulations to Anna-Lena for her paper published in JExpMed on impaired respiratory burst in PKCd deficient patients. For more information click here.
Congratulations to Miri and Mania for their cover story and review about alveolar macrophages in lung homeostasis and targeted therapies. For more information click here.
Read our latest overview about the potential of macrophages and upcoming therapies. For more information click here.
Den Körper mit Zellen heilen zu können – dieses ehrgeizige Ziel verfolgen Wissenschaftlerinnen und Wissenschaftler der Medizinischen Hochschule Hannover (MHH). Professor Dr. Nico Lachmann und Dr. Robert Zweigerdt haben dafür nun mit der pharmazeutischen Firma Novo Nordisk A/S eine Forschungskooperation vereinbart.
For more information click here.
The publication "Ackermann et al. 2020" shows new insights in the development of human blood stem cells. Ackermann and colleagues used IPSC and organoids to show the formation of blood cells.
The publication „Hahn/Pollmann et al. 2020“ sets the foundation for the first gene therapy of IFNgR1-deficient MSMD. The authors reverse cells from patients with lentiviral vectors. For more information click here.
“Haake et al. 2020“ provides insights into the formation of Mendelian Suscpetibility to Mycobacterial Disease. IPSC from patients are established and point out to be important cells for MSMD. For more information click here.
We are proud to announce that Jenny Lam, our first MD student, successfully defended her MD thesis on macrophages,iPSC and the disease model for IFNGR1 deficiency!
We are happy to announce, that our group head is now associate professor (W2) at Hannover Medical School investigating new forms of treatment targeting infections of the lower respiratory tract.
The American Society for Gene and Cell Therapy (ASGCT) awards the work of Kathrin Haake with an “Excellence in Research” award.